Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Conditions: Breast Cancer (Locally Advanced or Metastatic), Healthy Volunteers (HV), Unhealthy Volunteers, Breast Cancer Screening

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: Yes

Enrollment: 450

Sponsor: University of Maryland, Baltimore

Location: University of Maryland Baltimore Washington Medical Center Glen Burnie Maryland

Summary

The purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.

Eligibility Criteria

Inclusion Criteria: * 18 years old or older * Patient of UMMS * Willing and able to consent to study procedures listed in the protocol * Ability to speak and understand English Exclusion Criteria: * Younger than 18 years old * Patient not cared for at UMMS * Unable to consent to study procedures listed in the protocol * Unable to speak or understand English

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07374796). StuddyBuddy aggregates publicly available trial information.